We specialize in providing biopharma and virtual organizations with human iPSC-derived cells and outsourced laboratory services to bolster drug discovery efforts. As experts in the realm of human induced pluripotent stem cell (iPSC) products and services, we are dedicated to advancing the development of more physiologically relevant in vitro models for the creation of safer and more effective therapies. Our iPSC capabilities facilitate the creation of advanced in vitro disease models and supply the necessary volume for cutting-edge platforms. Whether it's developing simple monoculture models or intricate co-culture, we remain at the forefront of harnessing the potential of iPSCs to drive innovation in research and drug discovery